TWC
INDV icon

TD Waterhouse Canada’s Indivior Pharmaceuticals INDV Stock Holding History

TD Waterhouse Canada’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.3K Sell
1,571
-1,025
-39% -$37.2K ﹤0.01% 1353
2026
Q1 		$79.4K Buy
2,596
+1,183
+84% +$39.1K ﹤0.01% 1253
2025
Q4 		$50.7K Hold
1,413
– – ﹤0.01% 1200
2025
Q3 		$33.2K Hold
1,413
– – ﹤0.01% 1284
2025
Q2 		$20.9K Hold
1,413
– – ﹤0.01% 1309
2025
Q1 		$13.5K Hold
1,413
– – ﹤0.01% 1349
2024
Q4 		$18.3K Hold
1,413
– – ﹤0.01% 1292
2024
Q3 		$13.7K Hold
1,413
– – ﹤0.01% 1301
2024
Q2 		$22.2K Hold
1,413
– – ﹤0.01% 1207
2024
Q1 		$40.4K Hold
1,413
– – ﹤0.01% 1099
2023
Q4 		$28.8K Hold
1,413
– – ﹤0.01% 1057
2023
Q3 		$40.7K Hold
1,413
– – ﹤0.01% 966
2023
Q2 		$43.2K Buy
+1,413
New +$32.4K ﹤0.01% 969

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

TD Waterhouse Canada's INDV Position: Q2 2026 in Review

TD Waterhouse Canada reduced its Indivior Pharmaceuticals (INDV) stake by 39% in Q2 2026, selling an estimated $37.2K and leaving 1,571 shares worth $63.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

TD Waterhouse Canada first reported a position in INDV in Q2 2023 and has held it in 13 quarters since. The position peaked at $79.4K in Q1 2026. 125 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • TD Waterhouse Canada held 1,571 shares of Indivior Pharmaceuticals worth $63.3K as of Q2 2026.
  • TD Waterhouse Canada sold 1,025 Indivior Pharmaceuticals shares in Q2 2026, an estimated $37.2K.
  • Indivior Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1353 holding.
  • TD Waterhouse Canada first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • TD Waterhouse Canada's Indivior Pharmaceuticals position peaked at $79.4K in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.